Carroll Financial Associates’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
LCOV
LCP
Carroll Financial Associates's HAE Position: Q2 2021 in Review
Carroll Financial Associates sold out of Haemonetics (HAE) in Q2 2021, closing a stake of 19 shares — an estimated $2K sold.
Carroll Financial Associates first reported a position in HAE in Q2 2017 and held it in 9 quarters. The position peaked at $10K in Q3 2018. 258 funds tracked by Wall St. Rank hold HAE as of Q2 2021.
- Carroll Financial Associates reported no remaining Haemonetics position as of Q2 2021 after selling out during the quarter.
- Carroll Financial Associates sold 19 Haemonetics shares in Q2 2021, an estimated $2K.
- Carroll Financial Associates first reported a position in Haemonetics in Q2 2017 and held it in 9 quarters.
- Carroll Financial Associates's Haemonetics position peaked at $10K in Q3 2018.
- 258 funds tracked by Wall St. Rank held Haemonetics as of Q2 2021.
Based on Carroll Financial Associates's 13F filing for Q2 2021, filed 13 Jul 2021.